A 2017 commentary mentions the Infectious Diseases Society of America (IDSA) recommends against prophylactic antimicrobial agents after basilar skull fracture and cerebrospinal fluid (CSF) leakage. This recommendation is based primarily on one randomized, single-center study with 109 patients. In this study, ceftriaxone 1 g BID was used, which is half the dosage recommended for meningitis treatment. Additionally, an unusually high rate of meningitis totally 20.1% ( 66% [8/12] if CSF leakage was present) was reported. This commentary challenges the IDSA recommendation against prophylactic antibiotic use in patients with CSF leak; however, the authors do not pose any correction or appropriate course of therapy. [1], [2]
A 2015 Cochrane review and meta-analysis on the prevention of meningitis in patients with basilar skull fractures does not include any studies which used cefazolin. However, ceftriaxone 1 g dosed daily and BID have been studied. A subanalysis of 789 patients with documented CSF leakage showed a significant advantage from prophylactic antibiotics, with an odds ratio (OR) of 0.61 (95% confidence interval [CI] 0.37-0.99); however, the heterogeneity of antibiotics used in the nonrandomized studies makes it difficult to interpret these results. Due to the overall paucity of data, this meta-analysis was not able to support prophylactic antibiotic use in patients with basilar skull fractures, whether there is evidence of CSF leakage or not. [2], [3]